Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Use, Safety, and Effectiveness of Viremic Hepatitis B Virus Donor Livers: A Potential Opportunity to Expand the Donor Pool.

Lee TC, Kaiser TE, Luckett K, Wima K, Winer LK, Morris MC, Kassam AF, Safdar K, Bari K, Anwar N, Quillin RC 3rd, Shah SA.

Liver Transpl. 2019 Oct;25(10):1581-1584. doi: 10.1002/lt.25595. Epub 2019 Aug 6. No abstract available.

PMID:
31273919
2.

Is Surgery Necessary? Endoscopic Management of Post-transplant Biliary Complications in the Modern Era.

Cortez AR, Morris MC, Brown NG, Winer LK, Safdar K, Poreddy S, Shah SA, Quillin RC 3rd.

J Gastrointest Surg. 2019 Jun 21. doi: 10.1007/s11605-019-04292-z. [Epub ahead of print]

PMID:
31228080
3.

The Forgotten Cause of Gastroparesis: Liver Cirrhosis.

Aloreidi K, Safdar K.

S D Med. 2019 Feb;72(2):58-59.

PMID:
30855731
4.

Changes in mechanical dyssynchrony in severe aortic stenosis patients undergoing transcatheter aortic valve replacement.

Truong V, Mazur W, Magier A, Broderick J, Safdar K, Volz B, Bartone C, Kereiakes DJ, Chung ES.

Echocardiography. 2019 Feb;36(2):243-248. doi: 10.1111/echo.14237. Epub 2019 Jan 9.

PMID:
30623480
5.

Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.

Luckett K, Kaiser TE, Bari K, Safdar K, Schoech MR, Apewokin S, Diwan TS, Cuffy MC, Anwar N, Shah SA.

J Am Coll Surg. 2019 Apr;228(4):560-567. doi: 10.1016/j.jamcollsurg.2018.12.004. Epub 2018 Dec 23.

PMID:
30586641
6.

Biowaiver studies of Metronidazole tablets (400mg): An alternative to In-vivo bioequivalence Studies.

Safdar KA, Naqvi SB, Usman S, Rehman S, Muhammad IN.

Pak J Pharm Sci. 2018 Nov;31(6):2411-2418.

PMID:
30473512
7.

Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.

Bari K, Luckett K, Kaiser T, Diwan T, Cuffy M, Schoech MR, Safdar K, Blackard JT, Apewokin S, Paterno F, Sherman KE, Zucker SD, Anwar N, Shah SA.

Hepatology. 2018 May;67(5):1673-1682. doi: 10.1002/hep.29704. Epub 2018 Mar 26.

PMID:
29205441
8.

Cardiac magnetic resonance tissue tracking in right ventricle: Feasibility and normal values.

Truong VT, Safdar KS, Kalra DK, Gao X, Ambach S, Taylor MD, Moore R, Taylor RJ, Germann J, Toro-Salazar O, Jefferies JL, Bartone C, Raman SV, Ngo T, Mazur W.

Magn Reson Imaging. 2017 May;38:189-195. doi: 10.1016/j.mri.2017.01.007. Epub 2017 Jan 16.

PMID:
28093270
9.

UBR-5, a Conserved HECT-Type E3 Ubiquitin Ligase, Negatively Regulates Notch-Type Signaling in Caenorhabditis elegans.

Safdar K, Gu A, Xu X, Au V, Taylor J, Flibotte S, Moerman DG, Maine EM.

G3 (Bethesda). 2016 Jul 7;6(7):2125-34. doi: 10.1534/g3.116.027805.

10.

Assessing the Queuing Process Using Data Envelopment Analysis: an Application in Health Centres.

Safdar KA, Emrouznejad A, Dey PK.

J Med Syst. 2016 Jan;40(1):32. doi: 10.1007/s10916-015-0393-1. Epub 2015 Nov 11.

PMID:
26558394
11.

Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts.

Bakman YG, Safdar K, Freeman ML.

Endoscopy. 2009 Dec;41(12):1095-8. doi: 10.1055/s-0029-1215317. Epub 2009 Nov 10.

PMID:
19904701
12.

Biliary tract complications after liver transplantation.

Safdar K, Atiq M, Stewart C, Freeman ML.

Expert Rev Gastroenterol Hepatol. 2009 Apr;3(2):183-95. doi: 10.1586/egh.09.4. Review.

PMID:
19351288
13.

Careful observation of hepatic portal venous gas following esophageal variceal band ligation.

Ahmed K, Atiq M, Richer E, Neff G, Kemmer N, Safdar K.

Endoscopy. 2008 Sep;40 Suppl 2:E103. doi: 10.1055/s-2007-966850. Epub 2008 Apr 1. No abstract available.

PMID:
19085707
14.

Liver transplantation trends for older recipients: regional and ethnic variations.

Kemmer N, Safdar K, Kaiser TE, Zacharias V, Neff GW.

Transplantation. 2008 Jul 15;86(1):104-7. doi: 10.1097/TP.0b013e318176b4c1.

PMID:
18622285
15.

Pancreatic hydrocele: an unusual manifestation of severe acute pancreatitis.

Atiq M, Budhani I, Snyder R, Safdar K, Khan A, Chauhan S.

Gastrointest Endosc. 2008 Aug;68(2):393-5. doi: 10.1016/j.gie.2007.11.030. Epub 2008 Mar 4. No abstract available.

PMID:
18308311
16.

Impact of geographic location on access to liver transplantation among ethnic minorities.

Kemmer N, Safdar K, Kaiser T, Zacharias V, Neff GW.

Transplantation. 2008 Jan 27;85(2):166-70. doi: 10.1097/TP.0b013e31816223f8.

PMID:
18212619
17.

Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy.

Atiq M, Holt AF, Safdar K, Weber F, Ravinuthala R, Jonas ME, Neff GW.

J Clin Gastroenterol. 2008 Feb;42(2):213-4. doi: 10.1097/01.mcg.0000225628.84168.25.

PMID:
18209596
18.

Intestinal schistosomiasis following orthotopic liver transplantation: a case report.

Ahmed K, Safdar K, Kemmer N, Atiq M, Wang J, Neff GW.

Transplant Proc. 2007 Dec;39(10):3502-4.

PMID:
18089421
19.

Outcomes in adult and pediatric liver transplantation among various ethnic groups.

Neff GW, Kemmer N, Kaiser T, Zacharias V, Majoras N, Safdar K.

Transplant Proc. 2007 Dec;39(10):3204-6.

PMID:
18089354
20.

The impact of Campath 1H induction in adult liver allotransplantation.

Tryphonopoulos P, Madariaga JR, Kato T, Nishida S, Levi DM, Moon J, Selvaggi G, De Faria W, Regev A, Bejarano P, Khaled A, Safdar K, Esquenazi V, Weppler D, Yoshida H, Ruiz P, Miller J, Tzakis AG.

Transplant Proc. 2005 Mar;37(2):1203-4.

PMID:
15848669
21.

Topical testosterone treatment for chronic allograft failure in liver transplant recipients with recurrent hepatitis C virus.

Neff GW, O'Brien CB, Shire NJ, DeManno A, Kahn S, Rideman E, Safdar K, Madariaga J, Rudich SR.

Transplant Proc. 2004 Dec;36(10):3071-4.

PMID:
15686697
22.

The long-term effects of immune suppression on liver transplant recipients with recurrent hepatitis C viral infection.

Neff GW, delaGarza J, Shire N, Nishida S, O'Brien CB, Safdar K, Madariaga J, Schiff E, Ruiz P.

Transplant Proc. 2004 Dec;36(10):3065-7.

PMID:
15686695
23.

Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.

Neff GW, O'Brien CB, Nery J, Shire NJ, Nishida S, delaGarza J, Montalbano M, Safdar K, Ruiz P, Rideman E, Gascon JA, Tzakis AG, Madariaga J, Rudich SM.

Liver Transpl. 2004 Dec;10(12):1497-503.

24.

Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy.

Neff GW, Montalbano M, O'Brien CB, Nishida S, Safdar K, Bejarano PA, Khaled AS, Ruiz P, Slapak-Green G, Lee M, Nery J, De Medina M, Tzakis A, Schiff ER.

Transplantation. 2004 Nov 15;78(9):1303-7.

PMID:
15548967
25.

Tenofovir therapy for lamivudine resistance following liver transplantation.

Neff GW, Nery J, Lau DT, O'Brien CB, Duncan R, Shire NJ, Ruiz P, Nery C, Montalbano M, Muslu H, Safdar K, Schiff ER, Tzakis AG, Madariaga JR.

Ann Pharmacother. 2004 Dec;38(12):1999-2004. Epub 2004 Oct 26.

PMID:
15507498
26.

Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade.

Neff GW, O'brien CB, Nery J, Shire N, Montalbano M, Ruiz P, Nery C, Safdar K, De Medina M, Tzakis AG, Schiff ER, Madariaga J.

Liver Transpl. 2004 Nov;10(11):1372-8.

27.

Beneficial effects of topical testosterone replacement in patients with end-stage liver disease.

Neff GW, O'Brien CB, Montalbano M, Meyer D, DeManno A, Muslu H, Safdar K, Kahn S, Nishida S, Schiff ER.

Dig Dis Sci. 2004 Aug;49(7-8):1186-9. No abstract available.

PMID:
15387344
28.

Alcohol and hepatitis C.

Safdar K, Schiff ER.

Semin Liver Dis. 2004 Aug;24(3):305-15. Review.

PMID:
15349807
29.

A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications.

Montalbano M, Neff GW, Yamashiki N, Meyer D, Bettiol M, Slapak-Green G, Ruiz P, Manten E, Safdar K, O'Brien C, Tzakis AG.

Transplantation. 2004 Jul 27;78(2):264-8.

PMID:
15280688
30.

Liver transplant for the septuagenarians: importance of patient selection.

Safdar K, Neff GW, Montalbano M, Meyer D, O'Brien C, Yamashiki N, Schiff E, Tzakis A.

Transplant Proc. 2004 Jun;36(5):1445-8.

PMID:
15251355
31.

Consumption of dietary supplements in a liver transplant population.

Neff GW, O'Brien C, Montalbano M, DeManno A, Kahn S, Safdar K, Nishida S, Tzakis A.

Liver Transpl. 2004 Jul;10(7):881-5.

32.
33.

Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency.

Neff GW, Montalbano M, Slapak-Green G, Meyer D, Berney T, Safdar K, Schiff ER, Tzakis AG.

Transplant Proc. 2003 Dec;35(8):3029-31.

PMID:
14697970
34.

Human immunodeficiency virus infection and stroke in young patients.

Qureshi AI, Janssen RS, Karon JM, Weissman JP, Akbar MS, Safdar K, Frankel MR.

Arch Neurol. 1997 Sep;54(9):1150-3.

PMID:
9311359
35.

Intracerebral hemorrhage in blacks. Risk factors, subtypes, and outcome.

Qureshi AI, Suri MA, Safdar K, Ottenlips JR, Janssen RS, Frankel MR.

Stroke. 1997 May;28(5):961-4.

PMID:
9158633
36.

Crack cocaine use and stroke in young patients.

Qureshi AI, Akbar MS, Czander E, Safdar K, Janssen RS, Frankel MR.

Neurology. 1997 Feb;48(2):341-5.

PMID:
9040718
37.

Stroke in young black patients. Risk factors, subtypes, and prognosis.

Qureshi AI, Safdar K, Patel M, Janssen RS, Frankel MR.

Stroke. 1995 Nov;26(11):1995-8.

PMID:
7482637
38.

Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage.

Qureshi AI, Safdar K, Weil J, Barch C, Bliwise DL, Colohan AR, Mackay B, Frankel MR.

Stroke. 1995 Oct;26(10):1764-7.

PMID:
7570722

Supplemental Content

Loading ...
Support Center